Reagents

Atezolizumab is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). Atezolizumab blocks the interaction of PD-L1 with programmed cell death protein 1 (PD-1) and CD80 receptors

Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S.

Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S.

Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S.

Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S.

Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S.

Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S.

Daratumumab (Darzalex) is a human monoclonal antibody that is approved by the U.S.

Daratumumab (Darzalex) is a human monoclonal antibody that is approved by the U.S.

Daratumumab (Darzalex) is a human monoclonal antibody that is approved by the U.S.

DYKDDDDK tag is an octapeptide tag that can be added to a protein using recombinant DNA technology. It can be fused to the N-terminus or C-terminus of a target protein to facilitate detection and purification.

DYKDDDDK tag is an octapeptide tag that can be added to a protein using recombinant DNA technology. It can be fused to the N-terminus or C-terminus of a target protein to facilitate detection and purification.